Effects of interleukin-1β Inhibition on blood pressure, incident hypertension, and residual inflammatory risk

Rothman, A.M.K. orcid.org/0000-0002-7847-4500, MacFadyen, J., Thuren, T. et al. (6 more authors) (2020) Effects of interleukin-1β Inhibition on blood pressure, incident hypertension, and residual inflammatory risk. Hypertension, 75 (2). pp. 477-482. ISSN 0194-911X

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2019 The Authors. Hypertension is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Keywords: myocardial infarction; blood pressure; diagnosis; inflammation; interleukins
Dates:
  • Accepted: 24 November 2019
  • Published (online): 30 December 2019
  • Published: February 2020
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Sheffield Teaching Hospitals
Funding Information:
FunderGrant number
WELLCOME TRUST (THE)206632/Z/17/Z
Depositing User: Symplectic Sheffield
Date Deposited: 07 Feb 2020 12:20
Last Modified: 07 Feb 2020 12:20
Status: Published
Publisher: American Heart Association
Refereed: Yes
Identification Number: https://doi.org/10.1161/hypertensionaha.119.13642

Share / Export

Statistics